Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of May 2026
John Fourier @John Fourier
Gold member since January 2017

Location: United States

Gender: Male

Asset investment style: Quantitative fundamental analysis

Market capitalization:

$8,002,461talents

Virtual portfolio value:

$4,968,116talents

Net overall return per annum:

18.67%

AYA current rank order:

#15

Asset investment philosophy:
John Fourier trades U.S. stocks with the top #276 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
MGRT Mega Fortune Company Limited Ordinary Shares $6.46 $135.97 2,176 +2,004.80% $281,814
SXTP 60 Degrees Pharmaceuticals Inc. Common Stock $0.15 $1.34 129,826 +793.33% $154,493
BQ Boqii Holding Limited American Depositary Shares representing Class A Ordinary Shares $0.36 $3.36 45,111 +833.33% $135,333
BQ Boqii Holding Limited Class A Ordinary Shares $0.36 $3.36 45,111 +833.33% $135,333
VATE INNOVATE Corp. Common Stock $0.53 $4.14 36,743 +681.13% $132,642
SSNT SilverSun Technologies Inc. Common Stock $18.59 $130.48 857 +601.88% $95,890
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 9,925 +2,108.33% $75,331
AXSM Axsome Therapeutics Inc. Common Stock $4.60 $31.75 1,441 +590.22% $39,123
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 951 +589.24% $39,058
SQ Block Inc. Class A Common Stock $14.50 $99.54 457 +586.48% $38,863
Sum $1,127,880

Top 10 current stock portfolio positions as of May 2026Strategy

Symbol Company Price Position Capitalization
DGXX Digi Power X Inc. Subordinate Voting Shares $7.43 6,212 $46,155
STKE Sol Strategies Inc. Common Shares $2.03 16,883 $34,272
SITM SiTime Corporation Common Stock $901.48 37 $33,354
AAON AAON Inc. Common Stock $141.70 224 $31,740
APT Alpha Pro Tech Ltd. Common Stock $6.64 4,551 $30,218
NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares $39.59 733 $29,019
QURE uniQure N.V. Ordinary Shares $27.64 1,049 $28,994
MBX MBX Biosciences Inc. Common Stock $40.08 692 $27,735
NTRBW Nutriband Inc. Warrant $1.53 17,894 $27,377
NVCT Nuvectis Pharma Inc. Common Stock $11.06 2,445 $27,041
Sum $315,905

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@Andy Yeh Alpha

Top 20 favorite stocks

#1 - #5 #6 - #10 #11 - #15 #15 - #20
$ZIM

Blog+More

The great reversal of antitrust merger review in America

Monica McNeil

2023-10-07 10:24:00 Saturday ET

The great reversal of antitrust merger review in America

Thomas Philippon draws attention to greater antitrust scrutiny in light of the rise of market power and its economic ripple effects. Thomas Philippon (20

+See More

MIT financial economist Simon Johnson rethinks capitalism with better key market incentives.

Daisy Harvey

2019-11-23 08:33:00 Saturday ET

MIT financial economist Simon Johnson rethinks capitalism with better key market incentives.

MIT financial economist Simon Johnson rethinks capitalism with better key market incentives. Johnson refers to the recent Business Roundtable CEO statement

+See More

OECD cuts the global economic growth forecast from 3.5% to 3.3% for the current fiscal year 2019-2020.

Rose Prince

2019-03-27 11:28:00 Wednesday ET

OECD cuts the global economic growth forecast from 3.5% to 3.3% for the current fiscal year 2019-2020.

OECD cuts the global economic growth forecast from 3.5% to 3.3% for the current fiscal year 2019-2020. The global economy suffers from economic protraction

+See More

Is higher stock market concentration good or bad for Corporate America?

Laura Hermes

2025-03-03 04:11:06 Monday ET

Is higher stock market concentration good or bad for Corporate America?

Is higher stock market concentration good or bad for Corporate America? In recent years, S&P 500 stock market returns exhibit spectacular concentrati

+See More

President Trump tweets that he asks the SEC to assess the practical implications of switching to a 6-month corporate disclosure cycle.

John Fourier

2018-08-17 11:45:00 Friday ET

President Trump tweets that he asks the SEC to assess the practical implications of switching to a 6-month corporate disclosure cycle.

In accordance with the extant corporate disclosure rules and requirements, all U.S. public corporations have to report their balance sheets, income statemen

+See More

The unique controversial management style of Steve Jobs helps translate his business acumen into smart product development.

Dan Rochefort

2020-03-26 10:31:00 Thursday ET

The unique controversial management style of Steve Jobs helps translate his business acumen into smart product development.

The unique controversial management style of Steve Jobs helps translate his business acumen into smart product development. Jay Elliot (2012) Leading

+See More